Financials Global Health Limited

Equities

MEDANTA

INE474Q01031

Healthcare Facilities & Services

End-of-day quote NSE India S.E. 06:00:00 2024-05-20 pm EDT 5-day change 1st Jan Change
1,335 INR -4.91% Intraday chart for Global Health Limited -3.85% +39.21%

Valuation

Fiscal Period: March 2023 2024 2025 2026
Capitalization 1 141,325 358,511 - -
Enterprise Value (EV) 1 141,325 354,739 349,526 345,288
P/E ratio 41.9 x 74.2 x 57.3 x 46.4 x
Yield - 0.21% 0.25% 0.3%
Capitalization / Revenue 5.25 x 10.8 x 9.31 x 7.82 x
EV / Revenue 5.25 x 10.8 x 9.08 x 7.54 x
EV / EBITDA 23.1 x 44.4 x 34.4 x 28.2 x
EV / FCF 34.6 x 128 x 113 x 68.1 x
FCF Yield 2.89% 0.78% 0.88% 1.47%
Price to Book 5.82 x 12.3 x 10.1 x 8.46 x
Nbr of stocks (in thousands) 268,195 268,507 - -
Reference price 2 527.0 1,335 1,335 1,335
Announcement Date 5/27/23 5/17/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2022 2023 2024 2025 2026
Net sales 1 - 26,942 32,751 38,490 45,824
EBITDA 1 - 6,122 7,991 10,173 12,259
EBIT 1 - 4,623 6,263 8,405 10,363
Operating Margin - 17.16% 19.12% 21.84% 22.61%
Earnings before Tax (EBT) 1 - 4,493 6,271 8,556 10,394
Net income 1 1,962 3,261 4,782 6,207 7,665
Net margin - 12.1% 14.6% 16.13% 16.73%
EPS 2 7.770 12.57 17.80 23.29 28.77
Free Cash Flow 1 - 4,085 2,751 3,090 5,067
FCF margin - 15.16% 8.2% 8.03% 11.06%
FCF Conversion (EBITDA) - 66.73% 32.32% 30.38% 41.33%
FCF Conversion (Net income) - 125.29% 55.82% 49.79% 66.11%
Dividend per Share 2 - - 2.800 3.300 4.000
Announcement Date 5/26/22 5/27/23 5/17/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 7,034 7,730 7,997 8,141 8,473
EBITDA 1 1,631 1,843 1,908 2,030 2,196
EBIT 1 1,252 1,439 1,510 1,650 1,728
Operating Margin 17.79% 18.62% 18.88% 20.27% 20.39%
Earnings before Tax (EBT) 1 1,331 1,410 1,537 1,634 1,863
Net income 1 1,011 1,020 1,094 1,173 1,304
Net margin 14.37% 13.2% 13.69% 14.41% 15.39%
EPS 2 3.760 3.800 4.100 4.300 4.600
Dividend per Share - - - - -
Announcement Date 5/27/23 8/10/23 - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2022 2023 2024 2025 2026
Net Debt 1 - - - - -
Net Cash position 1 - - 7,080 8,985 13,223
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - 4,085 2,751 3,090 5,067
ROE (net income / shareholders' equity) - 16.1% 18.6% 19.3% 19.8%
ROA (Net income/ Total Assets) - 8.98% 11.7% 13% 13.5%
Assets 1 - 36,307 42,153 47,648 56,700
Book Value Per Share 2 - 90.50 108.0 132.0 158.0
Cash Flow per Share - - - - -
Capex 1 - 2,360 4,457 4,632 4,635
Capex / Sales - 8.76% 13.29% 12.03% 10.11%
Announcement Date 5/26/22 5/27/23 5/17/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1,335 INR
Average target price
1,384 INR
Spread / Average Target
+3.67%
Consensus
  1. Stock Market
  2. Equities
  3. MEDANTA Stock
  4. Financials Global Health Limited
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW